BEONE MEDICINES LTD. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised
BEONE MEDICINES LTD. (ONC) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised of $34.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions · last filed 2026-08-05
- BEONE MEDICINES LTD. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2026-06-30 was $11.05M, a 66.67% decline year-over-year.
- BEONE MEDICINES LTD. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2026-03-31 was $23.88M, a 62.32% decline year-over-year.
- BEONE MEDICINES LTD. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2025-12-31 was $19.24M, a 118.79% increase year-over-year.
- BEONE MEDICINES LTD. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2025-09-30 was $80.53M, a 396.42% increase year-over-year.
- BEONE MEDICINES LTD. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2025 was $196.28M, a 332.59% increase from fiscal 2024.
- BEONE MEDICINES LTD. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2024 was $45.37M, a 18.56% decline from fiscal 2023.
- BEONE MEDICINES LTD. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2023 was $55.71M, a 18.63% increase from fiscal 2022.
- BEONE MEDICINES LTD. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2022 was $46.96M, a 49.37% decline from fiscal 2021.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $34.92M 10-Q · filed 2026-08-05 | $54.17M derived: sum of 3 quarters · filed 2026-08-05 | $134.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $23.88M 10-Q · filed 2026-05-06 | $43.12M derived: sum of 2 quarters · filed 2026-05-06 | $123.65M derived: sum of 3 quarters · filed 2026-05-06 | $156.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $19.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $99.78M derived: sum of 2 quarters · filed 2026-02-26 | $132.92M derived: sum of 3 quarters · filed 2026-08-05 | $196.28M 10-K · filed 2026-02-26 |
| 2025-09-30 | $80.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $113.68M derived: sum of 2 quarters · filed 2026-08-05 | $177.04M 10-Q · filed 2025-11-06 | $185.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $33.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $96.50M 10-Q · filed 2026-08-05 | $105.30M derived: sum of 3 quarters · filed 2026-08-05 | $121.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $63.36M 10-Q · filed 2026-05-06 | $72.15M derived: sum of 2 quarters · filed 2026-05-06 | $88.38M derived: sum of 3 quarters · filed 2026-05-06 | $93.94M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.02M derived: sum of 2 quarters · filed 2026-02-26 | $30.58M derived: sum of 3 quarters · filed 2026-02-26 | $45.37M 10-K · filed 2026-02-26 |
| 2024-09-30 | $16.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $21.79M derived: sum of 2 quarters · filed 2025-11-06 | $36.58M 10-Q · filed 2025-11-06 | $39.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $20.36M 10-Q · filed 2025-08-06 | $23.71M derived: sum of 3 quarters · filed 2026-02-26 | $40.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $14.79M 10-Q · filed 2025-05-07 | $18.15M derived: sum of 2 quarters · filed 2026-02-26 | $35.33M derived: sum of 3 quarters · filed 2026-02-26 | $38.91M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.54M derived: sum of 2 quarters · filed 2026-02-26 | $24.12M derived: sum of 3 quarters · filed 2026-02-26 | $55.71M 10-K · filed 2026-02-26 |
| 2023-09-30 | $17.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $20.76M derived: sum of 2 quarters · filed 2024-11-12 | $52.35M 10-Q · filed 2024-11-12 | $63.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $35.17M 10-Q · filed 2024-08-07 | $46.46M derived: sum of 3 quarters · filed 2025-02-27 | $63.16M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $31.59M 10-Q · filed 2024-05-08 | $42.88M derived: sum of 2 quarters · filed 2025-02-27 | $59.58M derived: sum of 3 quarters · filed 2025-02-27 | $66.67M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $11.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $27.99M derived: sum of 2 quarters · filed 2025-02-27 | $35.08M derived: sum of 3 quarters · filed 2025-02-27 | $46.96M 10-K · filed 2025-02-27 |
| 2022-09-30 | $16.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $23.80M derived: sum of 2 quarters · filed 2023-11-09 | $35.68M 10-Q · filed 2023-11-09 | $46.25M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $18.97M 10-Q · filed 2023-08-02 | $29.54M derived: sum of 3 quarters · filed 2024-02-26 | $76.13M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $11.88M 10-Q · filed 2023-05-04 | $22.45M derived: sum of 2 quarters · filed 2024-02-26 | $69.04M derived: sum of 3 quarters · filed 2024-02-26 | $78.89M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $10.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $57.16M derived: sum of 2 quarters · filed 2024-02-26 | $67.01M derived: sum of 3 quarters · filed 2024-02-26 | $92.76M 10-K · filed 2024-02-26 |
| 2021-09-30 | $46.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $56.44M derived: sum of 2 quarters · filed 2022-11-09 | $82.19M 10-Q · filed 2022-11-09 | $99.46M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $9.85M 10-Q · filed 2021-08-05 | $35.60M 10-Q · filed 2022-08-08 | $52.87M derived: sum of 3 quarters · filed 2023-02-27 | $100.50M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $25.75M 10-Q · filed 2022-05-09 | $43.02M derived: sum of 2 quarters · filed 2023-02-27 | $90.66M derived: sum of 3 quarters · filed 2023-02-27 | $107.23M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $17.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $64.90M derived: sum of 2 quarters · filed 2023-02-27 | $81.47M derived: sum of 3 quarters · filed 2023-02-27 | $93.10M 10-K · filed 2023-02-27 |
| 2020-09-30 | $47.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $64.20M derived: sum of 2 quarters · filed 2021-11-04 | $75.83M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $16.57M 10-Q · filed 2021-08-05 | $28.20M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $11.63M 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $47.00M 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $29.66M 10-K · filed 2021-02-25 |